Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Lupus patients face dramatically higher stroke risk, new research shows. A meta-analysis of over 5 million individuals found that systemic lupus erythematosus (SLE) more than doubles the risk of stroke — both ischemic and hemorrhagic types. Researchers say SLE should now be firmly recognized as an independent, major stroke risk factor.
A large-scale meta-analysis has confirmed that systemic lupus erythematosus (SLE) significantly raises the risk of stroke. Analyzing data from 25 cohort studies involving more than 5.2 million individuals, researchers found that SLE patients were more than 2.5 times more likely to experience a stroke compared to those without the condition — and the elevated risk applied to both major stroke types.
The findings, published in Lupus Science & Medicine, underscore the need for proactive cardiovascular monitoring in lupus patients, who are already managing a complex autoimmune disease. While most studies in the analysis accounted for traditional cardiovascular risk factors, the researchers noted that SLE's contribution to stroke risk appears to be independent of those factors.
By the Numbers:
Why it matters: For clinicians managing lupus patients, this meta-analysis is a strong reminder that stroke prevention strategies — including blood pressure control, anticoagulation review, and cardiovascular risk assessment — should be a routine part of SLE care.
